Founders Financial Alliance’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305K Sell
1,360
-31
-2% -$7.72K 0.06% 294
2025
Q4
$335K Sell
1,391
-11
-0.8% -$2.81K 0.06% 258
2025
Q3
$384K Buy
1,402
+18
+1% +$4.92K 0.07% 247
2025
Q2
$357K Sell
1,384
-88
-6% -$21K 0.08% 228
2025
Q1
$330K Buy
+1,472
New +$344K 0.08% 234
2020
Q4
Sell
-3
Closed -$1K 1071
2020
Q3
$1K Buy
+3
New +$554 ﹤0.01% 1313

Other funds holding RMD

Founders Financial Alliance's RMD Position: Q1 2026 in Review

Founders Financial Alliance reduced its ResMed (RMD) stake by 2.2% in Q1 2026, selling an estimated $7.72K and leaving 1,360 shares worth $305K. The position accounts for 0.06% of the portfolio, ranked #294.

Founders Financial Alliance first reported a position in RMD in Q3 2020 and has held it in 6 quarters since. The position peaked at $384K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Founders Financial Alliance held 1,360 shares of ResMed worth $305K as of Q1 2026.
  • Founders Financial Alliance sold 31 ResMed shares in Q1 2026, an estimated $7.72K.
  • ResMed made up 0.06% of Founders Financial Alliance's portfolio in Q1 2026, its #294 holding.
  • Founders Financial Alliance first reported a position in ResMed in Q3 2020 and has held it in 6 quarters since.
  • Founders Financial Alliance's ResMed position peaked at $384K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.